In a comprehensive review of over 10,000 studies, researcher Ryan Castle and his team have presented compelling evidence on the role of medical cannabis in cancer care, published in the journal Frontiers. The findings suggest that cannabis may be effective not only in managing symptoms such as pain, nausea, and appetite loss commonly associated with cancer and chemotherapy, but also shows early potential in helping to inhibit tumour growth and support the body’s own defences against cancer. The review highlights how specific cannabinoids, such as THC and CBD, interact with the endocannabinoid system to modulate inflammation, cell proliferation, and immune responses. While the study emphasises the need for more clinical trials, it reinforces the view that medical cannabis could play a dual role in both symptom management and therapeutic intervention—potentially reshaping integrative cancer care.
